Fiera Capital Corp Royalty Pharma PLC Transaction History

Fiera Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$39.88 - $44.65 $330,007 - $369,478	-8,275 Reduced 18.53%	36,375 $1.46 Million
Q2 2022 Aug 10, 2022	SELL	$37.53 - $44.22 $132,668 - $156,317	-3,535 Reduced 7.34%	44,650 $1.88 Million
Q1 2022 May 09, 2022	SELL	$37.46 - $42.44 $760,438 - $861,532	-20,300 Reduced 29.64%	48,185 $1.88 Million
Q4 2021 Feb 08, 2022	BUY	$35.17 - $42.48 $300,000 - $362,354	8,530 Added 14.23%	68,485 $2.73 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $2.17 Million - $2.53 Million	59,955 New	59,955 $2.17 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.